Fed. Circ. Invalidates 5 Of Mallinckrodt's Inomax Patents
A split Federal Circuit panel dealt a blow to Mallinckrodt on Tuesday, agreeing with a Delaware federal judge that five of its patents covering the respiratory drug Inomax are invalid, and...To view the full article, register now.
Already a subscriber? Click here to view full article